Antiinflammatory effects of cucurbitacins and sorafenib in Hepg2 cells by modulating the IκB/NF-κB/COX-2 pathway through Akt signaling
Turkish Journal of Biology · 26.06.2025 · 49 (3) · 309-323
DOI: 10.55730/1300-0152.2747 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Biology, online erschienen am 26.06.2025. Verfasst von Muhammed Mehdi Üremiş und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Faculty of Medicine, İnönü University, Malatya, Turkiye. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
Cucurbitacins possess antitumor, antiproliferative, and antiinflammatory properties. This study aims to examine the antiinflammatory effects of CuD, CuI, and CuE on NF-κB, iNOS, COX-2, and Akt and compare their cytotoxic and antiinflammatory effects on HepG2 cells with sorafenib, the primary chemotherapeutic agent used in HCC treatment.
Methods
Cytotoxic effects of cucurbitacins and sorafenib on HepG2 cells were evaluated using MTT and LDH assays, along with Annexin V, MMP, and comet assays. Levels of proteins related to the Akt/NF-κB pathway and COX-2, iNOS, and NO were also measured.
Results
Our study showed that CuD, CuI, CuE, and sorafenib have antiproliferative and cytotoxic effects on HepG2 cells. Cucurbitacins induced apoptosis at lower concentrations than sorafenib and, like sorafenib, reduced p-Akt, p-IκBα protein levels, and nuclear translocation of NF-κB in a dose-dependent manner. Moreover, all compounds significantly decreased COX-2, iNOS, and NO levels, especially at 5 μM concentration.
Conclusion
These results indicate that cucurbitacins exert antiinflammatory effects on HepG2 cells by modulating the PI3K/Akt/NFκB signaling pathway, thereby reducing COX-2, iNOS, and NO levels. These effects are similar to those of sorafenib.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Biochemistry, Faculty of Medicine, İnönü University, Malatya, Turkiye.
ORCID-Profile: Muhammed Mehdi Üremiş, Yusuf Türköz, Nuray Üremiş
Zitieren
APA
Üremiş, M. M., Türköz, Y., & Üremiş, N. (2025). Antiinflammatory effects of cucurbitacins and sorafenib in Hepg2 cells by modulating the IκB/NF-κB/COX-2 pathway through Akt signaling. Turkish Journal of Biology, 49(3), 309-323. https://doi.org/10.55730/1300-0152.2747
Vancouver
Üremiş MM, Türköz Y, Üremiş N. Antiinflammatory effects of cucurbitacins and sorafenib in Hepg2 cells by modulating the IκB/NF-κB/COX-2 pathway through Akt signaling. Turkish Journal of Biology. 2025;49(3):309-323. doi:10.55730/1300-0152.2747
BibTeX
@article{remi2025,
author = {Üremiş, Muhammed Mehdi and Türköz, Yusuf and Üremiş, Nuray},
title = {Antiinflammatory effects of cucurbitacins and sorafenib in Hepg2 cells by modulating the IκB/NF-κB/COX-2 pathway through Akt signaling},
journal = {Turkish Journal of Biology},
year = {2025},
volume = {49},
number = {3},
pages = {309--323},
doi = {10.55730/1300-0152.2747}
}
EUVIMED